NCT01922856View on ClinicalTrials.gov

Challenge Study of an ETEC Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 19, 2013

Primary Completion Date

February 6, 2016

Study Completion Date

July 14, 2016

Conditions
Enteritis; Escherichia Coli, Enterotoxigenic
Interventions
BIOLOGICAL

LTR192G with dscCfaE

Recombinant fimbrial adhesin (dscCfaE) with Modified Escherichia coli (E coli) heat labile enterotoxin (LTR192G)

OTHER

No Intervention

Controls only receive challenge

Trial Locations (2)

20910

Naval Medical Research Center, Silver Spring

21205

Johns Hopkins Center for Immunization Research, Baltimore

All Listed Sponsors
lead

U.S. Army Medical Research and Development Command

FED

NCT01922856 - Challenge Study of an ETEC Vaccine | Biotech Hunter | Biotech Hunter